TERFIMED 250 MG TBL NOB 14 I
Rychlý přehled
| Dosage form | Tablets uncoated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 176,58 Kč. Maximální cena: 219,77 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Terbinafin-hydrochlorid (281,28 mg), terbinafin (250 mg), sodná sůl karboxymethylškrobu (typ a), mikrokrystalická celulosa, hypromelosa, koloidní bezvodý oxid křemičitý, magnesium-stearát. Další informace o složení lze… |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 16. 7. 2013. Výroba byla ukončena s platností od 26. 7. 2013. The manufacturer lists medicines with the following code as a potential substitute: 00014210102518 |
| Kód SÚKL | 0106144 |
What is the maximum co-payment for TERFIMED?
If the insurance company contributes, the maximum co-payment is 176,58 Kč. The maximum pharmacy price is 219,77 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does TERFIMED have a counted co-payment set?
Yes, the medicine has a counted co-payment of 142,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
43,19 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe TERFIMED?
Prescription is not conditional on a medical specialization.
What is the composition of TERFIMED?
Terbinafin-hydrochlorid (281,28 mg), terbinafin (250 mg), sodná sůl karboxymethylškrobu (typ a), mikrokrystalická celulosa, hypromelosa, koloidní bezvodý oxid křemičitý, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to TERFIMED?
The medicine belongs to ATC group D01BA02 – Terbinafin. Medicines with the same active substance can be found here.
Who manufactures TERFIMED?
PRO.MED.CS PRAHA A.S., PRAHA (CZ)
Is the medicine in shortage?
The latest report from the manufacturer is from 16. 7. 2013. Production was terminated with effect from 26. 7. 2013. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for TERFIMED?
The medicine has code 0106144. Code details can be found here.
How many packs of TERFIMED were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of TERFIMED were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026